Product image
InVivoMAb anti-mouse NKG2D
BE0111
Overview
- SupplierBio X Cell
- Product NameInVivoMAb anti-mouse NKG2D
- Delivery Days Customer7
- ApplicationsNeutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDHMG2D
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHamster
- IsotypeIgG
- ReactivityMouse
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Lymphocytic Choriomeningitis Virus Expands a Population of NKG2D+CD8+ T Cells That Exacerbates Disease in Mice Coinfected with Leishmania major. Crosby EJ et al., 2015 Oct 1, J ImmunolRead more
- Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection. Crosby EJ et al., 2014 Feb, PLoS PathogRead more
- NKG2D blockade attenuated cardiac allograft vasculopathy in a mouse model of cardiac transplantation. Chen H et al., 2013 Sep, Clin Exp ImmunolRead more
- Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth. Hervieu A et al., 2013 Feb, J Invest DermatolRead more
- Promotion of liver regeneration by natural killer cells in a murine model is dependent on extracellular adenosine triphosphate phosphohydrolysis. Graubardt N et al., 2013 May, HepatologyRead more
- IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence. Mandaric S et al., 2012, PLoS PathogRead more
- NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses. Zloza A et al., 2012 Feb 26, Nat MedRead more
- NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Ito A et al., 2008 Oct, Int ImmunolRead more